rs6900057
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_020320.5(RARS2):c.111-19T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0487 in 1,532,826 control chromosomes in the GnomAD database, including 2,386 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.072 ( 547 hom., cov: 33)
Exomes 𝑓: 0.046 ( 1839 hom. )
Consequence
RARS2
NM_020320.5 intron
NM_020320.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.20
Genes affected
RARS2 (HGNC:21406): (arginyl-tRNA synthetase 2, mitochondrial) This nuclear gene encodes a protein that localizes to the mitochondria, where it catalyzes the transfer of L-arginine to its cognate tRNA, an important step in translation of mitochondrially-encoded proteins. Defects in this gene are a cause of pontocerebellar hypoplasia type 6 (PCH6). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-87564251-A-C is Benign according to our data. Variant chr6-87564251-A-C is described in ClinVar as [Benign]. Clinvar id is 261218.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-87564251-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.143 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RARS2 | NM_020320.5 | c.111-19T>G | intron_variant | ENST00000369536.10 | NP_064716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RARS2 | ENST00000369536.10 | c.111-19T>G | intron_variant | 1 | NM_020320.5 | ENSP00000358549.5 |
Frequencies
GnomAD3 genomes AF: 0.0719 AC: 10938AN: 152172Hom.: 547 Cov.: 33
GnomAD3 genomes
AF:
AC:
10938
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0446 AC: 11125AN: 249614Hom.: 363 AF XY: 0.0430 AC XY: 5802AN XY: 135030
GnomAD3 exomes
AF:
AC:
11125
AN:
249614
Hom.:
AF XY:
AC XY:
5802
AN XY:
135030
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0461 AC: 63682AN: 1380536Hom.: 1839 Cov.: 24 AF XY: 0.0450 AC XY: 31137AN XY: 691880
GnomAD4 exome
AF:
AC:
63682
AN:
1380536
Hom.:
Cov.:
24
AF XY:
AC XY:
31137
AN XY:
691880
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0719 AC: 10945AN: 152290Hom.: 547 Cov.: 33 AF XY: 0.0696 AC XY: 5184AN XY: 74478
GnomAD4 genome
AF:
AC:
10945
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
5184
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
102
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Pontocerebellar hypoplasia type 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 17
Find out detailed SpliceAI scores and Pangolin per-transcript scores at